Potential utility of BimS as a novel apoptotic therapeutic molecule (Q40521096)

21 September 2017

title

Potential utility of BimS as a novel apoptotic therapeutic molecule (English)

1 reference

21 September 2017

1 reference

1 reference

21 September 2017

Brian O'sullivan

0 references

Kenneth W Yip

1 reference

21 September 2017

Anna Li

1 reference

21 September 2017

Jian-Hua Li

1 reference

21 September 2017

Wei Shi

1 reference

21 September 2017

Marie C Chia

1 reference

21 September 2017

Shahnaz Al Rashid

1 reference

21 September 2017

Joseph D Mocanu

1 reference

21 September 2017

Alexander V Louie

1 reference

21 September 2017

Otto Sanchez

1 reference

21 September 2017

Dolly Huang

1 reference

21 September 2017

Pierre Busson

1 reference

21 September 2017

Wen-Chen Yeh

1 reference

21 September 2017

Ralph Gilbert

1 reference

21 September 2017

Patrick Gullane

1 reference

21 September 2017

publication date

1 September 2004

1 reference

21 September 2017

1 reference

21 September 2017

1 reference

21 September 2017

1 reference

21 September 2017

page(s)

533-544

1 reference

Epidemiology of nasopharyngeal carcinoma.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study. Is combined modality treatment really necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Epstein-Barr virus in the pathogenesis of NPC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Efficacy of targeted FasL in nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Bim: a novel member of the Bcl-2 family that promotes apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

BH3-Only proteins-essential initiators of apoptotic cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

The significance of LMP1 expression in nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Adenoviral natural born killer gene therapy for malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Adenovirus-mediated transfer of caspase-8 augments cell death in gliomas: implication for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Validating survivin as a cancer therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

The Survivin saga goes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Cancer gene therapy using a survivin mutant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Apoptosis-based therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Senescence, apoptosis and therapy--cutting the lifelines of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Adenovirus-mediated transfer of bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Retroviral immunotoxin gene therapy of leukemia in mice using leukemia-specific T cells transduced with an interleukin-3/Bax fusion protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Mammalian caspases: structure, activation, substrates, and functions during apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Two CD95 (APO-1/Fas) signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Apoptosis: getting rid of the bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Induced apoptosis supports spread of adenovirus vectors in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Adenovirus-p53 gene therapy in human nasopharyngeal carcinoma xenografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.026

10.1016/J.YMTHE.2004.05.026

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference